资料显示，山东潍坊润丰化工股份有限公司位于山东省济南市高新区汉峪金融商务中心五区5号楼 3001，成立日期2005年6月23日，上市日期2021年7月28日，公司主营业务涉及农药原药及制剂的研发、 生产和销售。主营业务收入构成为：除草剂72.04%，杀虫剂16.26%，杀菌剂10.33%，其他1.14%，其他 (补充)0.22%。 从基金十大重仓股角度 11月4日，润丰股份跌2.11%，截至发稿，报71.80元/股，成交1.08亿元，换手率0.54%，总市值201.59亿 元。润丰股份股价已经连续4天下跌，区间累计跌幅7.95%。 截至发稿，刘莎莎累计任职时间11年67天，现任基金资产总规模14.02亿元，任职期间最佳基金回报 31.67%， 任职期间最差基金回报-1.7%。 钱大千累计任职时间2年319天，现任基金资产总规模16.64亿元，任职期间最佳基金回报41.27%， 任职 期间最差基金回报0%。 风险提示：市场有风险，投资需谨慎。本文为AI大模型自动发布，任何在本文出现的信息（包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成个人投资建 议。 责任编辑：小浪快报 ...

投资建议与投资标的 ⚫ 我们看好在绿色聚酯产业中已领先布局关键节点的万凯新材(301216，买入)。短期 受贸易争端影响较小的农药制剂环节，如润丰股份(301035，买入)、国光股份 (002749，买入)、海利尔(603639，买入)等。同时也看好"反内卷"政策预期驱动 下，石化与化工行业有望出现景气复苏，主要相关标的包括中国石化(600028，买 入)、恒力石化(600346，买入)、荣盛石化(002493，买入)、万华化学(600309，买 入)、华谊集团(600623，买入)；。 风险提示 ⚫ 需求不及预期；海外市场供需情况变化；油价大幅波动。 国家/地区 中国 行业 基础化工行业 报告发布日期 2025 年 11 月 03 日 看好（维持） 基础化工行业 行业研究 | 行业周报 中美会谈顺利需求端有望修复，储能高速 增长利好磷矿景气 核心观点 | 倪吉 | 执业证书编号：S0860517120003 | | --- | --- | | | niji@orientsec.com.cn | | | 021-63326320 | | 万里扬 | 执业证书编号：S0860519090003 | | | wa ...

润丰股份 301035.SZ 公司研究 | 季报点评 盈利能力持续提升，严控风险轻装上阵 核心观点 盈利预测与投资建议 ⚫ 我们预测 25-27 年公司 EPS 分别为 4.10、4.89、5.94 元，给予可比公司 25 年 21 倍 PE，对应目标价 86.10 元，维持买入评级。 风险提示： ⚫ 市场开拓不及预期；海外经营不确定性风险；原材料等成本波动风险。 公司主要财务信息 | | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入(百万元) | 11,485 | 13,296 | 15,073 | 17,376 | 19,900 | | 同比增长 (%) | -20.6% | 15.8% | 13.4% | 15.3% | 14.5% | | 营业利润(百万元) | 945 | 435 | 1,517 | 1,834 | 2,246 | | 同比增长 (%) | -46.8% | -54.0% | 248.7% | 20.9% | 22.4% | | 归属母公司净利润(百万元) | ...

Core Viewpoint - Runfeng Co., Ltd. is a leading player in the domestic pesticide formulation industry, focusing on the research, production, and sales of pesticide active ingredients and formulations, with a global marketing network and multiple R&D and manufacturing bases [1] Group 1: Business Performance - In Q3 2025, Runfeng's revenue reached 10.911 billion yuan, ranking third among 32 companies in the industry, with the top competitor, Adama Agricultural Solutions, at 21.678 billion yuan [2] - The revenue composition includes herbicides at 4.705 billion yuan (72.04%), insecticides at 1.062 billion yuan (16.26%), fungicides at 675 million yuan (10.33%), and other products at 74.644 million yuan (1.14%) [2] - The net profit for the same period was 999 million yuan, ranking second in the industry, with the average net profit being 171 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, Runfeng's debt-to-asset ratio was 55.83%, down from 57.15% year-on-year, which is higher than the industry average of 46.06% [3] - The gross profit margin for Q3 2025 was 22.08%, an increase from 20.36% year-on-year, surpassing the industry average of 21.70% [3] Group 3: Executive Compensation - The chairman, Wang Wencai, received a salary of 1.6532 million yuan in 2024, an increase of 15,800 yuan from 2023 [4] - The president, Shen Jie, earned 1.1792 million yuan in 2024, up by 42,500 yuan from the previous year [4] Group 4: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 2.90% to 6,630, while the average number of shares held per shareholder increased by 2.99% to 42,300 shares [5] - The top ten circulating shareholders include various funds, with notable changes in their holdings [5] Group 5: Future Outlook - Longjiang Securities projects that Runfeng will achieve net profits of 1.17 billion, 1.34 billion, and 1.61 billion yuan from 2025 to 2027, maintaining a "buy" rating [5] - Shanxi Securities anticipates net profits of 1.14 billion, 1.31 billion, and 1.60 billion yuan for the same period, with corresponding price-to-earnings ratios of 19, 17, and 14 times [6]

Investment Rating - The investment rating for the company is "Buy" and it is maintained [10]. Core Insights - The company reported a revenue of 10.91 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 11.5%. The net profit attributable to shareholders reached 890 million yuan, up 160.5% year-on-year, while the net profit after deducting non-recurring gains and losses was 880 million yuan, an increase of 159.2% year-on-year. In Q3 alone, the company achieved a revenue of 4.38 billion yuan, a year-on-year increase of 6.8% and a quarter-on-quarter increase of 13.9%. The net profit for Q3 was 330 million yuan, up 109.1% year-on-year and 11.8% quarter-on-quarter [2][7]. Summary by Sections Financial Performance - For the first three quarters of 2025, the company achieved a revenue of 10.91 billion yuan, with a net profit of 890 million yuan and a net profit after deducting non-recurring items of 880 million yuan. In Q3, the revenue was 4.38 billion yuan, with a net profit of 330 million yuan [2][7]. - The company recorded a gross margin of 23.1% in Q3, an increase of 2.5 percentage points year-on-year, and a net margin of 8.5%, up 4.0 percentage points year-on-year [14]. Market Position and Strategy - The company is a leading player in the domestic pesticide formulation industry, with a strong global presence, including 120 subsidiaries and operations in over 100 countries. It has established seven manufacturing bases across various regions [14]. - The company has been focusing on increasing its TOC (Team-Operated Company) business, which saw its revenue share rise from 38.02% to 43.25% year-on-year, with a gross margin increase from 29.59% to 31.80% [14]. - The company aims to enhance its market share through a five-year strategic plan that includes increasing TOC business, expanding North American and European operations, and strengthening the biopesticide segment [14]. Industry Outlook - The pesticide market is expected to continue its steady growth, supported by a rigid global demand for crop protection products. The global pesticide sales reached 80.17 billion USD in 2022, with a year-on-year growth of 9.2% [14]. - The global pesticide industry has entered a mature phase, characterized by oligopolistic competition, with the top five companies holding a 75% market share [14].

Core Viewpoint - The company reported significant growth in Q3 2025, with revenue reaching 4.381 billion yuan and net profit of 334 million yuan, driven by reduced exchange losses and expansion in high-value regions and to C business [1] Group 1: Financial Performance - In Q3 2025, the company achieved a revenue increase of 6.76% quarter-on-quarter and 13.95% year-on-year, while net profit surged by 109.13% quarter-on-quarter and 11.80% year-on-year [1] - The gross profit margin for Q3 2025 was 23.08%, reflecting a year-on-year increase of 2.52 percentage points and a quarter-on-quarter increase of 0.16 percentage points [2] Group 2: Business Segments - The revenue share from North America and Europe increased to 13.6%, up by 2.7 percentage points year-on-year, with the to C business revenue share rising to 41.39%, an increase of 3.66 percentage points year-on-year [2] - The to C business revenue share for Q3 2025 was 43.25%, showing a year-on-year increase of 5.23 percentage points and a quarter-on-quarter increase of 1.9 percentage points [2] - The share of insecticides and fungicides in the product mix increased to 31.70% in Q3 2025, up by 5.58 percentage points quarter-on-quarter and 4.44 percentage points year-on-year [2] Group 3: Industry Outlook - The agricultural chemical industry is experiencing a recovery phase, with China's agricultural chemical exports in Q3 2025 reaching 2.612 billion USD, a year-on-year increase of 21.61% [3] - The export price of agricultural chemicals was 2.96 USD/kg in Q3 2025, showing a gradual increase since the beginning of the year [3] - China maintains strong export competitiveness in agricultural chemicals due to low costs and a complete supply chain, indicating a positive outlook for the industry's recovery [3] Group 4: Investment Recommendations - The company is expected to achieve net profits of 1.14 billion, 1.31 billion, and 1.60 billion yuan for 2025, 2026, and 2027, respectively, with corresponding PE ratios of 19, 17, and 14 times [4] - The company's global operations, growth in high-value regions, and improvements in product quality are viewed positively, maintaining a "Buy-B" rating [4]

Group 1 - The core point of the news is that Runfeng Co., Ltd. experienced a decline of 5.12% in its stock price, reaching 74.01 yuan per share, with a total market capitalization of 20.78 billion yuan [1] - Runfeng Co., Ltd. is primarily engaged in the research, production, and sales of pesticide raw materials and formulations, with its main business revenue composition being: herbicides 72.04%, insecticides 16.26%, fungicides 10.33%, and others 1.14% [1] Group 2 - From the perspective of fund holdings, only one fund under Baoying Fund has a significant position in Runfeng Co., Ltd., specifically Baoying Xianghe 9-month open-end mixed A fund, which increased its holdings by 100 shares to a total of 800 shares, accounting for 0.26% of the fund's net value [2] - The Baoying Xianghe 9-month open-end mixed A fund has a total scale of 21.04 million yuan and has achieved a year-to-date return of 4%, ranking 7157 out of 8152 in its category [2]

Investment Rating - The report maintains a "Buy-B" rating for the company [1][4]. Core Views - The company has shown significant improvement in its performance for Q3 2025, with revenues reaching 4.381 billion yuan, representing a quarter-on-quarter increase of 6.76% and a year-on-year increase of 13.95%. The net profit attributable to the parent company was 334 million yuan, with a year-on-year increase of 109.13% and a quarter-on-quarter increase of 11.80% [1]. - The growth in revenue is attributed to a reduction in foreign exchange losses and an increase in high-value-added regions and to C business scale [1][2]. - The company is focusing on enhancing its high-value-added product offerings, with the proportion of revenue from North America and Europe increasing to 13.6%, up by 2.7 percentage points year-on-year. The to C business revenue proportion has risen to 41.39%, an increase of 3.66 percentage points year-on-year [2]. - The gross profit margin for Q3 2025 was 23.08%, reflecting a year-on-year increase of 2.52 percentage points and a quarter-on-quarter increase of 0.16 percentage points [2]. - The company is also increasing the proportion of insecticides and fungicides, which now account for 31.70% of its product mix, up by 5.58 percentage points quarter-on-quarter and 4.44 percentage points year-on-year [2]. Financial Data and Valuation - The projected net profits for the company from 2025 to 2027 are 1.14 billion yuan, 1.308 billion yuan, and 1.604 billion yuan, corresponding to price-to-earnings (PE) ratios of 19, 17, and 14 times respectively [4]. - The company’s revenue for 2023 is reported at 11.485 billion yuan, with projections of 13.296 billion yuan for 2024 and 14.122 billion yuan for 2025 [6][14].

证券代码：301035 证券简称：润丰股份 公告编号：2025-062 山东潍坊润丰化工股份有限公司 关于高级管理人员减持计划实施完成的公告 2025 年 10 月 29 日收到公司股东沈婕女士、邢秉鹏先生出具的《关于股份 减持计划实施完毕的告知函》，上述减持计划已实施完成。具体情况如下： | | | | | | | | 减持股份数 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | 减持 | | 减持期间 | | 减持均价 | 减持股 | 量占目前公 | 减持股份 | | 名称 | 方式 | | | | （元/股） | 数（股） | 司总股本的 | 来源 | | | | | | | | | 比例 | | | 沈婕 | 集中竞 | 2025 | 年 10 | 月 | 28 日 75.44 | 18,033 | 0.0065% | 股权激励 | | | 价交易 | | | | | | | 股份 | | 邢秉鹏 | 集中竞 | 2025 | 年 10 月 | | 27 日 76.36 | 25,584 | 0.0092% | 股权激 ...

Core Viewpoint - The pesticide sector experienced a significant rally in the afternoon, with multiple companies reaching their daily price limits [1] Company Performance - Changqing Co. and Yangnong Chemical both hit the daily limit up [1] - Liming Co., Runfeng Co., Hailier, Xin'an Co., and Guangxin Co. also saw increases in their stock prices [1]